You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

List of Excipients in API tocilizumab-aazg

✉ Email this page to a colleague

« Back to Dashboard

Detailed excipient profiles for tocilizumab-aazg

Excipient focus: ARGININE

tocilizumab-aazg drug variants containing ARGININE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Fresenius Kabi USA LLC	tocilizumab-aazg	65219-586
Fresenius Kabi USA LLC	tocilizumab-aazg	65219-590
>Company	>Ingredient	>NDC

tocilizumab-aazg drug variants not containing ARGININE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: HISTIDINE

tocilizumab-aazg drug variants containing HISTIDINE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Fresenius Kabi USA LLC	tocilizumab-aazg	65219-586
Fresenius Kabi USA LLC	tocilizumab-aazg	65219-590
>Company	>Ingredient	>NDC

tocilizumab-aazg drug variants not containing HISTIDINE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: HYDROCHLORIC ACID

tocilizumab-aazg drug variants containing HYDROCHLORIC ACID

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Fresenius Kabi USA LLC	tocilizumab-aazg	65219-586
Fresenius Kabi USA LLC	tocilizumab-aazg	65219-590
>Company	>Ingredient	>NDC

tocilizumab-aazg drug variants not containing HYDROCHLORIC ACID

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: LACTIC ACID, L-

tocilizumab-aazg drug variants containing LACTIC ACID, L-

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Fresenius Kabi USA LLC	tocilizumab-aazg	65219-586
Fresenius Kabi USA LLC	tocilizumab-aazg	65219-590
>Company	>Ingredient	>NDC

tocilizumab-aazg drug variants not containing LACTIC ACID, L-

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: POLYSORBATE 80

tocilizumab-aazg drug variants containing POLYSORBATE 80

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Fresenius Kabi USA LLC	tocilizumab-aazg	65219-586
Fresenius Kabi USA LLC	tocilizumab-aazg	65219-590
>Company	>Ingredient	>NDC

tocilizumab-aazg drug variants not containing POLYSORBATE 80

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SODIUM CHLORIDE

tocilizumab-aazg drug variants containing SODIUM CHLORIDE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Fresenius Kabi USA LLC	tocilizumab-aazg	65219-586
Fresenius Kabi USA LLC	tocilizumab-aazg	65219-590
>Company	>Ingredient	>NDC

tocilizumab-aazg drug variants not containing SODIUM CHLORIDE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SODIUM HYDROXIDE

tocilizumab-aazg drug variants containing SODIUM HYDROXIDE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Fresenius Kabi USA LLC	tocilizumab-aazg	65219-586
Fresenius Kabi USA LLC	tocilizumab-aazg	65219-590
>Company	>Ingredient	>NDC

tocilizumab-aazg drug variants not containing SODIUM HYDROXIDE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: WATER

tocilizumab-aazg drug variants containing WATER

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Fresenius Kabi USA LLC	tocilizumab-aazg	65219-586
Fresenius Kabi USA LLC	tocilizumab-aazg	65219-590
>Company	>Ingredient	>NDC

tocilizumab-aazg drug variants not containing WATER

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.